Cardiac muscle repair or regeneration using bone marrow-derived stem cells
AssigneeMesoblast International Sarl
InventorsMark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay
Life of this patent
Estimating the term…
Abstract
Disclosed are compositions and methods for method of treating a subject having reduced cardiac function or cardiac disease by administering adult bone marrow-derived stem cells to an individual. In some embodiments, the subject is a myocardial infarction patient or congestive heart failure patient. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
Claims21
A method of treating a subject having reduced cardiac function or a cardiac disease comprising the step of:
- administering to the subject bone marrow-derived stem cells, wherein the bone marrow-derived stem cells engraft to the subject's heart and promote myogenesis, and wherein the bone marrow-derived stem cells do not express the cell surface marker CD45.
Dependencies are inferred from the claim text.